HomMed monitoring system gets US FDA clearance:
This article was originally published in Clinica
HomMed has received US FDA 510(k) clearance for its home monitoring system aimed at patients with health problems associated with age or with chronic conditions, such as diabetes, asthma, chronic obstructive pulmonary disease or congestive heart failure. The HomMed Sentry, a small device placed in the user's home, alerts its user daily to collect vital sign data. The data is then transported to the HomMed Observer which delivers a report to a clinician via wireless technology or traditional telephone lines, said the Brookfield, Wisconsin-based company.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.